Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 6/20 | 0.43 |
| ▸ | CNR1 | P21554 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HTR2A | P28223 | 5/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TTR | P02766 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 3/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26684865 | 0.98 | HTR2A (0.43) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL26684590 | 0.86 | CNR2 (0.46) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL26684636 | 0.84 | CNR2 (0.45) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL30038814 | 0.82 | HTR2A (0.44) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL19943971 | 0.78 | ABCB1 (0.45) | CNR2CNR1KDM4EABCB1MEN1 | |
| SCHEMBL5358992 | 0.78 | ABCB1 (0.45) | CNR2CNR1HTR2AABCB1MEN1 | |
| SCHEMBL16011697 | 0.77 | ABCB1 (0.44) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL30668190 | 0.76 | CNR2 (0.41) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL30668194 | 0.74 | PGK1 (0.42) | CNR2CNR1KDM4EALDH1A1HTR2A | |
| SCHEMBL9865505 | 0.74 | ALDH1A1 (0.46) | KDM4EALDH1A1MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250382250-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | NANJING GRITPHARMACO LTD (CN) | 2025-12-18 | — | — | US | disclosed |
| EP-4524123-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | Nanjing Gritpharmaco., Ltd. (CN) | 2025-03-19 | — | — | EP | disclosed |
| WO-2023217049-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | 南京济群医药科技股份有限公司 | 2023-11-16 | — | — | WO | disclosed |
| CN-117003620-A | Stilbene derivatives as AhR agonists and uses thereof | 南京济群医药科技股份有限公司 | 2023-11-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382250-A1 | STILBENE DERIVATIVE AS AHR AGONIST AND USE THEREOF | AHR, ARNT, RORB | CNR2 277/4885CNR1 284/4885KDM4E 2993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.